Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)

China flag China · Delayed Price · Currency is CNY
28.54
+0.24 (0.85%)
Jul 10, 2026, 3:00 PM CST
Market Cap9.02B -29.1%
Revenue (ttm)1.93B +5.2%
Net Income309.27M -37.0%
EPS0.98 -38.4%
Shares Out 316.05M
PE Ratio29.18
Forward PEn/a
Dividend0.35 (1.23%)
Ex-Dividend DateJun 12, 2026
Volume2,647,832
Open28.24
Previous Close28.30
Day's Range27.90 - 29.26
52-Week Range25.70 - 50.86
Beta0.35
Analystsn/a
Price Targetn/a
Earnings DateAug 26, 2026

About SHA:688076

Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company, engages in the research and development, production, and sale of peptides, oligonucleotides, and small molecule drugs in China. The company offers Peptide CDMO Services,GMP oligo, full-time equivalent, discovery, generic APIs, and formulation services. It is also involved in professional technical services. The company was founded in 2009 and is headquartered in Hangzhou, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 2,360
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688076
Full Company Profile

Financial Performance

In 2025, SHA:688076's revenue was 1.94 billion, an increase of 19.57% compared to the previous year's 1.62 billion. Earnings were 332.42 million, a decrease of -17.80%.

Financial Statements